Dylan Dupuis analyst

Currently out of the existing stock ratings of Dylan Dupuis, 4 are a BUY (100%).

Dylan Dupuis

Work Performance Price Targets & Ratings Chart

Analyst Dylan Dupuis, has had 50% of price targets met with an average potential upside of 40.2%, reached in 112 days on average. Previously, Dylan Dupuis worked at ROTH MKM.

Dylan Dupuis has documented 8 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on IVA, Inventiva Sa at 21-Sep-2023.

Wall Street Analyst Dylan Dupuis

Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for VKTX (VIKING THERAPEUTICS) on 8/10/2023. The price target of $32 was fulfilled within 188 days with a profit of $17.12 (115.05%), with a performance score of 6.12.

Average potential price target upside

IVA Inventiva Sa VKTX Viking Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Sep-2025

$14

$10.86 (345.86%)

$24

16 days ago
(04-Nov-2026)

0/4 (0%)

$10.37 (285.67%)

Buy Since 19-Mar-2026

$18

$14.84 (469.62%)

$13

1 months 19 days ago
(02-Oct-2026)

0/2 (0%)

$14.44 (405.62%)

Buy Since 27-Oct-2023

$21

$17.86 (568.79%)

$20

1 months 23 days ago
(29-Sep-2026)

0/5 (0%)

$17.71 (538.30%)

Buy Since 27-Aug-2025

$26

$22.86 (728.03%)

$26

2 months 5 days ago
(16-Sep-2026)

0/3 (0%)

$22.21 (586.02%)

Buy Since 17-Nov-2025

$14

$10.86 (345.86%)

$11

2 months 6 days ago
(15-Sep-2026)

0/3 (0%)

$10.14 (262.69%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?